News Headline Summary

Amgen (AMGN) says its working with FDA on Sensipar development

Reaction details (17:16)

- No immediate reaction seen in Co. shares, traded last USD 89.29 (-0.29%)

26 Feb 2013 - 17:15 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: